Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-10-25-Speech-2-044"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20051025.4.2-044"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, Commissioner, what our fellow citizens require is high quality information and they are waiting for us to take the initiative and to tell them clearly how things stand.
Firstly, it emerged from last week’s informal meeting held by the ‘Health’ Council that some Member States still do not have any real emergency plan. We ought to be aware of this, Commissioner. We need to be aware of it! There needs to be transparency, because it is up to us to make these governments acknowledge their responsibilities. The European Commission has to show that it is taking a firm stance on the matter, and I would even say that, on behalf of the general public, it has to go beyond some of its prerogatives in order to make sure that the emergency plans are coordinated flawlessly. We have to break away from this European schizophrenia, which says that the Member States’ prerogatives should not be infringed. What will people say when a pandemic occurs? Commissioner, no one will ever criticise you for having saved lives, but they will condemn you, and severely too, for having been overcautious.
Then, in the context of researching a new vaccine, the European Union needs to provide its financial support in order both to help develop the vaccines and to make sure that studies related to them are well coordinated, and to encourage mass production of these vaccines. I understand that this research also includes a section on paediatrics. As we proposed in our resolution, it therefore seems crucial to use the Solidarity Fund, in particular to ensure that the Member States carry out these tasks in full. Commissioner, I know that this matter is now Mr Verheugen’s responsibility but, when the pharmaceutical legislation was revised, we adopted a measure conditionally authorising products to be placed on the market, making it possible to save time. What will have become of this important procedure in the event of a pandemic occurring? I get the impression that it has been left behind in a drawer somewhere. We must not wait until the epidemic arrives before we deal with it. I am counting on you to shake Mr Verheugen into action and to put in place an effective system for authorising products to be placed on the market more quickly."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples